Request for Nominations for the Board of Governors of the Patient-Centered Outcomes Research Institute (PCORI), 22406 [2024-06777]
Download as PDF
<![CDATA[
22406
Federal Register / Vol. 89, No. 63 / Monday, April 1, 2024 / Notices
and wealth building, with a particular
focus on the concerns of low- and
moderate-income consumers and
communities. Candidates do not have to
be experts on all topics related to
consumer financial services or
community development, but they
should possess some basic knowledge of
these areas and related issues. In
appointing members to the CAC, the
Board will consider a number of factors,
including diversity in terms of subject
matter expertise, geographic
representation, and the representation of
women and minority groups.
CAC members must be willing and
able to make the necessary time
commitment to participate in
organizational conference calls and
prepare for and attend meetings two
times per year (usually for two days).
The meetings will be held at the Board’s
offices in Washington, DC. The Board
will provide a nominal honorarium and
will reimburse CAC members only for
their actual travel expenses subject to
Board policy.
By order of the Board of Governors of
the Federal Reserve System, acting
through the Director of the Division of
Consumer and Community Affairs
under delegated authority, March 25,
2024.
of receipt will be provided within a
week of submission.
DATES: Letters of nomination and
resumes should be submitted no later
than May 3, 2024, to ensure adequate
opportunity for review and
consideration of nominees prior to
appointment.
Ann E. Misback,
Secretary of the Board.
[CMS–3441–N]
[FR Doc. 2024–06766 Filed 3–29–24; 8:45 am]
Medicare, Medicaid, and CLIA
Programs; Clinical Laboratory
Improvement Amendments of 1988
Exemption of Laboratories Licensed
by the State of Washington
BILLING CODE 6210–01–P
GOVERNMENT ACCOUNTABILITY
OFFICE
Government Accountability
Office (GAO).
ACTION: Request for letters of
nomination and resumes.
AGENCY:
The Patient Protection and
Affordable Care Act gave the
Comptroller General of the United
States responsibility for appointing up
to 21 members to the Board of
Governors of the Patient-Centered
Outcomes Research Institute. In
addition, the Directors of the Agency for
Healthcare Research and Quality and
the National Institutes of Health, or their
designees, are members of the Board. As
the result of terms ending in September
2024, GAO is accepting nominations in
the following category: a representative
of a Federal health program or agency.
Nominations should be sent to the email
address listed below. Acknowledgement
ddrumheller on DSK120RN23PROD with NOTICES1
VerDate Sep<11>2014
17:17 Mar 29, 2024
Jkt 262001
Gene L. Dodaro,
Comptroller General of the United States.
[FR Doc. 2024–06777 Filed 3–29–24; 8:45 am]
BILLING CODE 1610–02–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice.
AGENCY:
Request for Nominations for the Board
of Governors of the Patient-Centered
Outcomes Research Institute (PCORI)
SUMMARY:
Submit letters of
nomination and resumes to PCORI@
gao.gov. Include PCORI nominations in
the subject line of the email.
FOR FURTHER INFORMATION CONTACT: Ray
Sendejas at (202) 512–7113 or
SendejasR@gao.gov if you do not
receive an acknowledgement or need
additional information. For general
information, contact GAO’s Office of
Public Affairs, (202) 512–4800.
Authority: 42 U.S.C. 1320e; 26 U.S.C.
9511.
ADDRESSES:
This notice announces that
laboratories located in and licensed by
the State of Washington that possess a
valid license under the Medical Test
Site law, chapter 70.42 of the Revised
Code of Washington, are exempt from
the requirements of the Clinical
Laboratory Improvement Amendments
of 1988 (CLIA) for a period of 4 years.
DATES: The exemption granted by this
notice is effective from April 1, 2024 to
April 1, 2028.
FOR FURTHER INFORMATION CONTACT:
Mary Hasan, (410) 786–6480.
SUPPLEMENTARY INFORMATION:
SUMMARY:
I. Background and Legislative
Authority
Section 353 of the Public Health
Service Act (PHSA), as amended by the
Clinical Laboratory Improvement
Amendments of 1988 (CLIA) (Pub. L.
100–578), which was enacted on
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
October 31, 1988, generally provides
that no laboratory may perform tests on
human specimens for the diagnosis,
prevention or treatment of any disease
or impairment of, or assessment of the
health of, human beings unless it has a
certificate to perform that category of
tests issued by the Secretary of the
Department of Health and Human
Services (HHS). Under section
1861(s)(17)(A) of the Social Security Act
(the Act), the Medicare program will
only pay for laboratory services if the
laboratory has an appropriate CLIA
certificate for the testing they conduct.
Under section 1902(a)(9)(C) of the Act,
State Medicaid plans will generally only
pay for laboratory services furnished by
CLIA-certified laboratories. Thus,
although subject to specified
exemptions and exceptions, laboratories
generally must have a current and valid
CLIA certificate to test human
specimens for the purposes noted above
to be eligible for payment for those tests
by the Medicare or Medicaid programs.
Regulations implementing section 353
of the PHSA are contained in 42 CFR
part 493.
Section 353(p)(2) of the PHSA
provides for the exemption of
laboratories from CLIA requirements in
States that enact legal requirements that
are equal to or more stringent than
CLIA’s statutory and regulatory
requirements. Section 353(p)(2) of the
PHSA is implemented in subpart E of
our regulations at 42 CFR part 493.
Sections 493.551(a) and 493.553 provide
that CMS may exempt from CLIA
requirements, for a period not to exceed
6 years, all State-licensed or Stateapproved laboratories in a State if the
State licensure program meets the
specified conditions. Section 493.559(a)
provides that CMS will publish a notice
in the Federal Register when CMS
grants an exemption to an approved
State licensure program. Section
493.559(b) provides that the notice will
include the following:
• The name of the State licensure
program.
• A description of how the laboratory
requirements of the State are equal to or
more stringent than those of part 493.
• The basis for granting the
exemption.
• The term of approval, not to exceed
6 years.
A. State of Washington’s Application for
CLIA Exemption of Its Laboratories
The State of Washington has applied
for exemption of its laboratories from
CLIA program requirements. The State
of Washington submitted all the
applicable information and attestations
required by §§ 493.551(a), 493.553, and
E:\FR\FM\01APN1.SGM
01APN1
]]>Agencies
[Federal Register Volume 89, Number 63 (Monday, April 1, 2024)]
[Notices]
[Page 22406]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-06777]
=======================================================================
-----------------------------------------------------------------------
GOVERNMENT ACCOUNTABILITY OFFICE
Request for Nominations for the Board of Governors of the
Patient-Centered Outcomes Research Institute (PCORI)
AGENCY: Government Accountability Office (GAO).
ACTION: Request for letters of nomination and resumes.
-----------------------------------------------------------------------
SUMMARY: The Patient Protection and Affordable Care Act gave the
Comptroller General of the United States responsibility for appointing
up to 21 members to the Board of Governors of the Patient-Centered
Outcomes Research Institute. In addition, the Directors of the Agency
for Healthcare Research and Quality and the National Institutes of
Health, or their designees, are members of the Board. As the result of
terms ending in September 2024, GAO is accepting nominations in the
following category: a representative of a Federal health program or
agency. Nominations should be sent to the email address listed below.
Acknowledgement of receipt will be provided within a week of
submission.
DATES: Letters of nomination and resumes should be submitted no later
than May 3, 2024, to ensure adequate opportunity for review and
consideration of nominees prior to appointment.
ADDRESSES: Submit letters of nomination and resumes to [email protected].
Include PCORI nominations in the subject line of the email.
FOR FURTHER INFORMATION CONTACT: Ray Sendejas at (202) 512-7113 or
[email protected] if you do not receive an acknowledgement or need
additional information. For general information, contact GAO's Office
of Public Affairs, (202) 512-4800.
Authority: 42 U.S.C. 1320e; 26 U.S.C. 9511.
Gene L. Dodaro,
Comptroller General of the United States.
[FR Doc. 2024-06777 Filed 3-29-24; 8:45 am]
BILLING CODE 1610-02-P
